tiprankstipranks
Advertisement
Advertisement

GLMD Stock Latest News

Galmed Pharmaceuticals Sets August 26, 2026 Annual Meeting to Approve Governance and Structural Changes
Company AnnouncementsGalmed Pharmaceuticals Sets August 26, 2026 Annual Meeting to Approve Governance and Structural Changes
2h ago
6K
GLMD
Galmed Pharmaceuticals Unveils Cardiac-Targeted Aramchol LNP Breakthrough
PremiumCompany Announcements
Galmed Pharmaceuticals Unveils Cardiac-Targeted Aramchol LNP Breakthrough
6d ago
6K
GLMD
Galmed announces development of novel LNP cardiac targeted Aramchol formulation
PremiumThe Fly
Galmed announces development of novel LNP cardiac targeted Aramchol formulation
6d ago
GLMD
Galmed Pharmaceuticals Reports Wider Q1 2026 Loss Amid Higher R&D Spending
PremiumCompany Announcements
Galmed Pharmaceuticals Reports Wider Q1 2026 Loss Amid Higher R&D Spending
14d ago
6K
GLMD
Galmed announces restructured acquisition terms for Colospan
PremiumThe Fly
Galmed announces restructured acquisition terms for Colospan
1M ago
GLMD
Galmed Pharmaceuticals Closes Amended All-Cash Colospan Acquisition With Earnout Structure
PremiumCompany AnnouncementsGalmed Pharmaceuticals Closes Amended All-Cash Colospan Acquisition With Earnout Structure
1M ago
6K
GLMD
Galmed Pharmaceuticals to Acquire Colospan and Commit $6 Million to European Expansion
Premium
Company Announcements
Galmed Pharmaceuticals to Acquire Colospan and Commit $6 Million to European Expansion
1M ago
6K
GLMD
Galmed to acquire Colospan in cash and stock deal
Premium
The Fly
Galmed to acquire Colospan in cash and stock deal
1M ago
GLMD
Galmed and Tissue Dynamics Reveal New Metabolic Target for Cardiac Fibrosis With Aramchol Combo
PremiumCompany Announcements
Galmed and Tissue Dynamics Reveal New Metabolic Target for Cardiac Fibrosis With Aramchol Combo
2M ago
6K
GLMD
Galmed and Tissue Dynamics’ two-drug combination targets cardiac fibrosis
PremiumThe Fly
Galmed and Tissue Dynamics’ two-drug combination targets cardiac fibrosis
2M ago
GLMD
Galmed and Tissue Dynamics’ two-drug combination targets cardiac fibrosis
PremiumThe Fly
Galmed and Tissue Dynamics’ two-drug combination targets cardiac fibrosis
2M ago
GLMD
Galmed Reports Fivefold Bioavailability Boost with New Aramchol Meglumine Oral Formulation
PremiumCompany Announcements
Galmed Reports Fivefold Bioavailability Boost with New Aramchol Meglumine Oral Formulation
2M ago
6K
GLMD
Galmed reports results from first-in-man PK study of Aramchol Meglumine
PremiumThe FlyGalmed reports results from first-in-man PK study of Aramchol Meglumine
2M ago
GLMD
Galmed partnering with Tissue Dynamics to develop cardiac fibrosis platform
Premium
The Fly
Galmed partnering with Tissue Dynamics to develop cardiac fibrosis platform
3M ago
GLMD
Galmed Pharmaceuticals Partners with Tissue Dynamics on Human Cardiac Fibrosis Platform
Premium
Company Announcements
Galmed Pharmaceuticals Partners with Tissue Dynamics on Human Cardiac Fibrosis Platform
3M ago
6K
GLMD
Galmed Pharmaceuticals Teams with Tel Aviv University on Aramchol for Metastatic Brain Cancer
PremiumCompany Announcements
Galmed Pharmaceuticals Teams with Tel Aviv University on Aramchol for Metastatic Brain Cancer
3M ago
6K
GLMD
Galmed announces research agreement with Ramot at Tel Aviv University
PremiumThe Fly
Galmed announces research agreement with Ramot at Tel Aviv University
3M ago
GLMD
Morning News Wrap-Up 4/9/26: Today’s Biggest Stock Market Stories!
PremiumMarket News
Morning News Wrap-Up 4/9/26: Today’s Biggest Stock Market Stories!
3M ago
AMD
DIA
Galmed Unveils Brain-Penetrant Aramchol Formulation, Expanding Flagship Drug Into CNS Diseases
PremiumCompany Announcements
Galmed Unveils Brain-Penetrant Aramchol Formulation, Expanding Flagship Drug Into CNS Diseases
3M ago
6K
GLMD
Why Is Galmed Pharmaceuticals Stock (GLMD) Up Today?
PremiumMarket NewsWhy Is Galmed Pharmaceuticals Stock (GLMD) Up Today?
3M ago
GLMD
Galmed announces development of brain penetrating formulation of Aramchol
Premium
The Fly
Galmed announces development of brain penetrating formulation of Aramchol
3M ago
GLMD
Galmed Pharmaceuticals Shareholders Approve Proposal at Special Meeting
Premium
Company Announcements
Galmed Pharmaceuticals Shareholders Approve Proposal at Special Meeting
5M ago
6K
GLMD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >